Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
Date:2/4/2008

share and therefore these measures do not reflect the full economic

effect of the reduction in value of those intangible assets.

-- Revenue growth rates stated on a constant currency basis, by their

nature, exclude the impact of foreign exchange, which may have a

material impact on GAAP net sales.

-- Other companies may calculate non-GAAP net income, non-GAAP net income

per diluted share, or regional and divisional revenue growth rates that

exclude the impact of foreign exchange differently than Boston

Scientific does, limiting the usefulness of those measures for

comparative purposes.

Compensation for Limitations Associated with Use of Non-GAAP Financial

Measures

Boston Scientific compensates for the limitations on its non-GAAP

financial measures by relying upon its GAAP results to gain a complete

picture of the Company's performance. The non-GAAP numbers focus instead

upon the core business of the Company, which is only a subset, albeit a

critical one, of the Company's performance.

The Company provides detailed reconciliations of each non-GAAP financial

measure to its most directly comparable GAAP measure in the accompanying

schedules, and Boston Scientific encourages investors to review these

reconciliations.

Usefulness of Non-GAAP Financial Measures to Investors

The Company believes that presenting non-GAAP net income, non-GAAP net

income per share, and regional and divisional revenue growth rates that

exclude the impact of foreign exchange in addition to the related GAAP

measures provides investors greater transparency to the information used

by Boston Scientific management for its financial and operational

decision-making and allows investors to see Boston Scientific's results

"through the eyes" of management. The Company further believes that

providing thi
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Boston Scientific to Participate in Merrill Lynch Conference
2. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
3. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
4. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
5. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
8. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
9. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ... general corporate purposes. Under the terms ...
(Date:12/24/2014)... 23, 2014 SoundConnect’s ... designed to introduce cutting edge communication technology, ... partners of platform upgrades. This webinar series ... users in their quest to leverage web ... According to SoundConnect’s Marketing Manager, Seanna Baumgartner, ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 The report ... at 19.7% by 2019. It also provides a carefully ... strategies and challenges for the market. , Full Copy ... the report, the global market for cell expansion will ... future. It expects this growth to be driven by ...
(Date:12/24/2014)... 2014 Sigma-Aldrich Corporation (NASDAQ: ... under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) ... 22, 2014, thereby completing the U.S. HSR Act ... of the Company by Merck KGaA, Darmstadt, Germany.  ... condition to closing the transaction, which remains subject ...
Breaking Biology Technology:Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3SoundConnect Launches Leading Edge Business Communications Webinar Series 2SoundConnect Launches Leading Edge Business Communications Webinar Series 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
... /PRNewswire/ - IntelliPharmaCeutics Ltd. (Delaware),is pleased to ... pilot,clinical trial for its new abuse-resistant, alcohol-resistant ... IntelliPharmaCeutics,Corp. of Toronto ("IntelliPharmaCeutics" or the "Company"). ... for its novel ReXista(TM) abuse and,alcohol resistant ...
... International,Corporation ("PAREXEL") (Nasdaq: PRXL ) today announced ... the clinical pharmacology business of,Synchron Research in Ahmedabad, ... bioanalytical laboratory in Poitiers, France to a subsidiary ... of the new agreement, PAREXEL,s ownership interest in,the ...
... Core Informatics announces,that it has completed a ... System (LIMS) product, the "Core LIMS",for Progenics ... biopharmaceutical,company located in Tarrytown, NY. As part ... from its previous data management system.,The newly ...
Cached Biology Technology:IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 2IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone 3PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France 2PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France 3PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France 4
(Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San ... catalyst that provides the connective tissue that enhances care ... them to easily share client-level information; earned a second ... expand to organizations serving seniors aging in community and; ... partner on December 11 th 4-6p. ...
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... has found that three commonly used herbicides can ... at possible effects on the Lange,s metalmark, an ... implications for other at-risk and endangered butterflies wherever ... and director of the WSU Puyallup Research and ...
... of Standards and Technology (NIST) has released a new ... Resources Damage Assessment (NRDA) in the wake of the ... the Louisiana coast. The new Standard Reference Material, Gulf ... as a quality control material for the ongoing environmental ...
... available in German . Sperm have only ... in their quest by emitting attractants. Calcium ions determine the beating ... Together with colleagues from the Max Planck Institute for the Physics ... from the caesar research centre in Bonn, an institute of the ...
Cached Biology News:Commonly used herbicides seen as threat to endangered butterflies 2NIST releases Gulf of Mexico crude oil reference material 2Sperm can count 2
... represents the state-of-the-art in permanent mounting ... permanent preservation of immunohistochemical organic insoluble ... Red, New Fuchsin, and any other ... tissue sections. Clarin can be used ...
... pLivSelect is a direct ... recombinant identification. Recombinant selection ... survival, eliminating the need ... This quick and inexpensive ...
... Express is the first fully automated proteomics ... transfer operations with complete data tracking. It ... colony picking through final protein expression and ... of delivering a plate to any of ...
... OLIGO is a multi-functional program ... oligonucleotides from a sequence file ... DNA sequencing, site-directed mutagenesis, and ... hybridization temperature and secondary structure ...
Biology Products: